Get the Stockscreener App
0.00
100.00%
-23.80
Tema Neuroscience And Mental Health Etf stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
See More
Previous Close:
$23.80
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$27.53
Tema Neuroscience And Mental Health Etf Stock (MNTL) Company Profile
Name
Tema Neuroscience And Mental Health Etf
Sector
Industry
Phone
-
Address
-
Compare MNTL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNTL
Tema Neuroscience And Mental Health Etf
|
0.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
321.80 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
652.21 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
655.49 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
253.58 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
580.70 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Neuroscience And Mental Health Etf Stock (MNTL) Latest News
Tema Surpasses $1bn AUM Two Years After Launch, Strengthens Team With Key Growth Hires - Business Wire
Vertex Pharmaceuticals Plunges 19.28%—What Crisis Unfolds in Biotech's Pain Frontier? - AInvest
Vertex Pharmaceuticals Plunges 19.23%—What Storm is Brewing in Biotech? - AInvest
Alnylam Pharmaceuticals Surges 3.79% Intraday – What’s Fueling This Sudden Rally? - AInvest
Weekly ETF Industry Recap: U.S., Europe, and Canada Highlights – June 30-July 4, 2025 - Trackinsight
Tema Announces Liquidation of Two ETFs - Business Wire
The Unseen Storm: How Section 899 Could Trigger a Foreign Capital Exodus from U.S. Equities - AInvest
Tema Launches the S&P 500 Historical Weight ETF Strategy (DSPY), First S&P 500 Concentration Innovation Since 2003 - Business Wire
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Hone Your Biotech Allocation With Neuroscience ETF MNTL - ETF Trends
Tema Launches World’s First Electrification ETF ($VOLT) - Business Wire
Where to Invest in Health Trends - Bloomberg.com
Tema ETFs CIO on the Power of Biotech as a Source of Return Yuri Khodjamirian on Opportunities to Invest in Biotech - CMC Markets
Pursuing A Better Way To Invest In Life Sciences | Opto Partners - CMC Markets
Biogen cost cuts drive profit beat, as Alzheimer's drug off to slow start - Reuters
Benzinga's 2024 Virtual Healthcare Summit: What's Next In Health? - Benzinga
Luma, Yieldstreet Expand Alts Partnership - FA Mag
Tema ETFs: A Better Way to Invest in Life Sciences - StreetInsider
Tema Launches Third Medical-Themed ETF - FA Mag
Active ETF Stat Pack - NYSE
This Week in ETFs: Closures Outnumber New ETFs - ETF Trends
Biotechnology ETF List - ETFdb.com
Tema Neuroscience And Mental Health Etf Stock (MNTL) Financials Data
There is no financial data for Tema Neuroscience And Mental Health Etf (MNTL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.73%
0.01%
Cap:
|
Volume (24h):